1-2 of 2
Pier Luigi Abbate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal analysis of richter syndrome risk and survival in CLL: The role of targeted therapy and molecular markers. experience at the fondazione policlinico gemelli in rome.

Free
Idanna Innocenti, Tommaso Quaranta, Francesco Iadevaia, Annamaria Tomasso, Luca Stirparo, Antonio Mosca, Alberto Fresa, Giulia Benintende, Florenzia Vuono, Feliciana Guglielmi, Pier Luigi Abbate, Arianna Bakacs, Dimitar Efremov, Eugenio Sangiorgi, Francesco Autore, Luca Laurenti
Journal: Blood
Blood (2025) 146 (Supplement 1): 5679.
https://doi.org/10.1182/blood-2025-5679
Published: 2025
Journal Articles

Absence of lymphocytosis after starting treatment with cbtki is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12.

Free
Luca Laurenti, Feliciana Guglielmi, Antonio Mosca, Candida Vitale, Maria Chiara Montalbano, Gianmarco Favrin, Isacco Ferrarini, Andrea Galitzia, Raffaella Pasquale, Massimo Moratti, Gioacchino Catania, Roberta Murru, Diana Giannarelli, Enrica Martino, Riccardo Moia, Antonella Zucchetto, Erika Tissino, Francesco Autore, Annamaria Tomasso, Luca Stirparo, Tommaso Quaranta, Pier Luigi Abbate, Valter Gattei, Gianluca Gaidano, Massimo Gentile, Mauro Krampera, Giuliana Farina, Marzia Varettoni, Marta Coscia, Idanna Innocenti
Journal: Blood
Blood (2025) 146 (Supplement 1): 5671.
https://doi.org/10.1182/blood-2025-5671
Published: 2025